Professional Documents
Culture Documents
By simultaneously improving care and reducing costs for health systems and their populations,
Population Health Management (PHM) is the primary enabling discipline of the transformation
to value-based care.
The Good, Bad and Often Ugly Early Resultsand Recent Successes
Population Health Management cannot fix broken healthcare systems, nor is it a panacea that can
indiscriminately open the spigot of services for all. When applied in this way, PHM increases costs with minimal
outcomes improvement. However, when PHM is built on the right foundations and focuses on the largest
inefficiencies, the results in savings and outcomes can be impressive.
Early results from Value-Based Care
models were mixed. Only 24% of
Medicare Pioneer Accountable Care
Organizations (ACOs) achieved their
goal of earning Shared Savings and
over a third of the original Pioneer
ACOs have exited the program.
Although physician-led ACOs had
better success than hospital-led ACOs,
few organizations had the proper
infrastructure. They could not
implement value-based, accountable
care. Nor could they provide sufficient
incentives to alter physician and
consumer behaviors to drive savings.
Hospitals such as Brigham lost 10s of
millions as they expanded services,
but were unable to control costs.
ACOs represented the first major Centers for Medicare & Medicaid Services initiative in value-based care
reimbursement models. Today, organizations are learning what is required to implement value-based care
[See Figure 1], how to focus resources for greatest impact, and how to align incentives to drive savings while
improving outcomes.
Several levers enable health systems
to achieve 20 40% savings from PHM
initiatives while improving outcomes
[see Figure 2]. These levers include:
Fee for service (FFS) Goal: Drive revenue by attracting patients and increasing expensive services
rendered and reimbursed.
Value-based care (VBC/PHM) Goal: Avoid costs and improve outcomes by preventing the need for
expensive services and driving efficient use of resources.
Running two conflicting business models is unsustainable. It requires two financial systems and physician
incentives must reward conflicting behaviors. This is so challenging, that health systems are divesting assets
that are in financial conflict with todays (yesterdays) fee for service world even though CEOs know they will
need these assets for value-based care. [See Figure 3.]
Because running two divergent business models within one care delivery system is not sustainable, the
transition to Value-Based Care for organizations cannot be gradual. Transition, for any system that successfully
implements VBC, is likely to be abrupt.
Figure 3: Health Systems Divesting Population Health Assets in a FFS World (2012)
4
When will this shift occur?
In 2014 Barclays estimated that the
percentage of Managed Care Revenue in
either performance based or ValueBased Reimbursement (VBR) contracts
would increase to 34% by 2018. [See
Figure 4.] With only a third of revenue
tied to value-based care, one would
assume that the shift would not occur
before 2018.
However, successful value-based care
has much higher profitability than feefor-service (FFS). Profitability for valueP4P: Pay for Performance
VBR: Value Based Revenue
based care implementations (also called
Fee-for-Value FFV) ranges from 20 40%, Figure 4: Percent Revenue from Value-Based Care Contracts
or 5x (~30% vs ~6%) the profitability of
Barclays Capital Inc.
successful fee-for-service.
When just 20% of lives are in value-based care contracts, profits from Fee-for-Value exceed profits from Feefor-Service [See Figure 5 from Oliver Wyman]. This analysis reflects the early years of implmentation, when
value-based care strategies generally are applied to highest risk/highest cost populations. Although this
overestimates average profitability across the entire patient population, it is accurate for early years of valuebased care implementations.
5
Although 2018 projections call for only 34% of
revenues from value-based care, VBC provides
most of the profits. For organizations that
implement PHM successfully, profits from VBC
likely will exceed profits from FFS much
quicker than 2018.
35%
34%
30%
30%
27%
25%
23%
20%
% of Managed
Care Revenue
20%
Profit from
Managed Care
Revenue
17%
0%
2013 2014 2015 2016 2017 2018
Application:
In practice, this means that
healthcare providers are
examining the patient
populations they serve and
attempting to apply best
practices, analytics and
connectivity to engage,
influence and coordinate
caregivers and patients in
ways that improve care and
reduce costs.
Barclays Capital Inc.7
6
Figure 7 illustrates examples of incumbent health plans expanding into patient care.
Figure 7: Examples of Health System Structural Changes The Advisory Board Company
However, as shown in Figure 8, no player has all the required capabilities
Figure 8: Capability Assessment of Health System Incumbents The Advisory Board Company
Donald G. Ross and David Feygin
7
In addition to the incumbents, Digital/Health IT disruptors are creating solutions that break down historic
siloes and barriers to efficient care delivery by addressing various aspects of what Oliver Wyman calls the
Hassle Map [Figure 9].
With the ultimate winner(s) unclear, the key is to focus on solving critical problems and inefficiencies
represented by the hassle map, as opposed to focusing on specific incumbents. During the transformation to
PHM, suppliers must solve problems first and remain flexible regarding the customer/channel.
Capabilities:
To improve a populations health, providers
must develop the capability to:
1) identify patients across healthcare
settings and systems,
2) stratify the patient population
based on individual patients clinical
and financial risk,
3) based on risk, engage providers to
coordinate care and engage the
patient as an active participant in
determining their health, and
4) measure the impact of these
actions on outcomes, cost and
patient satisfaction.
Barclays Capital Inc.7
8
Figure 10 illustrates the capabilities needed for population health. Because most capabilities require
information technology, Health IT is intrinsically linked to, and a key enabler of, Population Health
Management.
Figure 11: Health IT and PHM EcoSystem Leaders Barclays Capital Inc. (2014)
Donald G. Ross and David Feygin
Even with new payer-delivery structures and aligned incentives, tactical implementation of population health
management encounters significant infrastructure barriers:
Data Collection Burden When data is not collected automatically, care providers are overburdened
with manual data entry.
Data Scarcity Because operational and clinical data becomes incredibly scarce outside the acute care
setting, actionable information is unavailable to manage care across the continuum.
Data connectivity and interoperability Even when data exists, it is a challenge to connect. Even
matching data to a specific patient requires extra efforts. Note: The U.S. is one of the few countries
without a unique patient identifier.
EMR/EHR connectivity A handful of major electronic medical record vendors are reluctant to provide
connectivity to potentially competitive solutions.
Reduced Volumes due to reduced overuse and more efficient resource utilization (reduced diagnostic
tests, reduced antibiotic use, fewer hospital visits, few medical supplies used)
Margin Pressure as product differentiation becomes less relevant than the economic and clinical
impact of system-level solutions
Channel Relevance decreases as health system C-suites look to system level solutions. Offerings that
are not top population health management priorities lose relevance
10
Questions to Consider
Who will be your customers in 5-7 years? (Payers, Providers, Health Systems?)
What are the priorities of your current customers and potential customers?
What Population Health Management initiatives are relevant to your offering?
Regardless of who your customers will be, are you positioned to solve healthcares key challenges and
address the hassle map?
Conclusions
The world is changing and the change is profound. Much like Health IT 5 years ago, it is now clear that the
transition to Value-Based Care is unstoppable. For innovators and entrepreneurs, this represents both a
tremendous opportunity and significant risk.
Dr. David Feygin is Vice President of Health IT Integration and Strategic Innovation at Becton Dickinson. David
also is Chair of the Executive Council for The Center for Patient Safety Research and Practice, a thought leader
in information-enabled healthcare safety with a primary focus on medication error and patient safety research.
David serves as a board member and co-Chair of the Digital Health Committee for the Life Science Angels, the
#1 ranked angel investor group in the US. He is an advisory board member for Health XL, a cross-industry
consortia devoted to care transformation. As a strategic advisor to several population health management
companies and through his work for Digital Health accelerators and incubators, David strives to help
entrepreneurs and companies develop profitable businesses that profoundly improve care quality and efficiency.
Don Ross is Board Director and Managing Partner Digital Health at Life Sciences Angels. He also is a member of
Sierra Angels and Sand Hill Angels, and was co-founder a group of private investors dedicated to investing in
digital health. Mr. Ross serves on several company boards and is a frequent speaker on entrepreneurship and
startup investing. He pioneered software development for psychological testing, anxiety intervention, health
risk appraisal, health behavior change, and blood pressure monitoring. Mr. Ross is a published author and has
two textbooks currently in 6th editions.
https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-andreports/nationalhealthexpenddata/nationalhealthaccountshistorical.html
2
http://resources.iom.edu/widgets/vsrt/healthcare-waste.html. See Appendix B for waste breakdown.
3
https://www.cms.gov/newsroom/mediareleasedatabase/fact-sheets/2015-fact-sheets-items/2015-02-27.html
4
Into the Minds of the C-Suite. Peer 60 Survey of 320 Hospital C-Suite executives. Peer60.com. Appendix A.
5
JP Morgan CIO Survey. November, 2014. Appendix A.
6
http://www.forbes.com/sites/brucejapsen/2015/05/15/value-based-care-may-drive-aetna-bid-for-cigna-or-humana/
7
Definitions of Population Health, Applications, and Capabilities from: Barclays Capital Inc., U.S. Healthcare Distribution & Technology:
HCIT: What we talk about When We Talk About Population Health, March, 2014
11
12
13
14